A phase I trial of caffeine to evaluate safety in infants with hypoxic-ischemic encephalopathy.

Journal of perinatology : official journal of the California Perinatal Association2024Jackson W, Gonzalez D, Greenberg RG, et al.

Study designOther primary literature

SubjectHuman

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

CaffeineHumansHypothermia, InducedHypoxia-Ischemia, BrainInfantNeuroprotection

DOI 10.1038/s41372-023-01752-y

PMID 37587184